COVID-19 Diagnostics: How Do Saliva Tests Compare to Swabs?

From hospitals and college campuses to remote villages in French Guiana, scientists have pit the two approaches against one other. See which one comes out ahead.

amanda heidt
| 6 min read
COVID-19, SARS-CoV-2, coronavirus, pandemic, saliva, testing, field testing, mass screening, methods, nasopharyngeal swab, techniques

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

ABOVE: © ISTOCK.COM, EVENFH

Since the early days of the pandemic, clinicians and researchers have been looking for alternatives to nasopharyngeal swabs. While samples collected from swabs are considered the gold standard in terms of generating accurate results, these tests require more supplies, place health care workers in closer contact with potentially infected individuals, and are difficult to scale up for mass testing. Saliva has been put forth as a low-cost, easy alternative, but it’s efficacy and accuracy remain points of contention.

Even as large universities have begun rolling out ambitious, saliva-based initiatives on campuses across the United States, private companies looking to develop rapid, in-home diagnostic tests have moved away from such tools. Trials of saliva-based testing being deployed in the field have yielded mixed results, and it remains unknown under what conditions saliva is most useful or how best it can be rolled into the existing testing framework.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • amanda heidt

    Amanda Heidt

    Amanda was an associate editor at The Scientist, where she oversaw the Scientist to Watch, Foundations, and Short Lit columns. When not editing, she produced original reporting for the magazine and website. Amanda has a master's in marine science from Moss Landing Marine Laboratories and a master's in science communication from UC Santa Cruz.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours